CB-010 ANTLER 2L LBCL and CB-011 CaMMouflage r/r MM Phase 1 clinical data expected in H1 2025 ---- Advancing four clinical programs for ...
10h
PRT3789 has demonstrated clinical proof-of-concept that selectively degrading SMARCA2 is generally safe and has monotherapy anti-tumor activity ...
The country’s largest automakers want to get into banking, hoping for a receptive audience from Trump-appointed officials ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback